What Is SNAP-8? Definition and What Research Reports

Plain-language definition

SNAP-8 is a marketing and trade name for a short synthetic peptide used as an ingredient in topical cosmetic products. It is built from eight amino acids, and its sequence copies a small piece of a human nerve protein called SNAP-25, which helps nerve endings release their chemical messengers. The idea behind the ingredient family is that a fragment resembling part of SNAP-25 may interfere with the assembly of the protein complex that drives that release, which in cosmetic marketing is described as a “relaxing” effect on expression lines. SNAP-8 is the longer cousin of a better-known peptide, acetyl hexapeptide-8 (sold as Argireline), and most published research in this area studied the hexapeptide rather than SNAP-8 itself.

This page is for educational purposes only and is not medical advice; consult a licensed physician about any health decision. Nothing here describes how any substance should be used.

What SNAP-8 is in chemical and regulatory terms

Naming

In ingredient labelling, SNAP-8 corresponds to the INCI name acetyl octapeptide-3 (also listed historically as acetyl glutamyl heptapeptide-1). The name “SNAP” is taken from synaptosomal-associated protein, and the “8” refers to the eight-residue chain length — not to a dose, a generation number or a potency rating. The molecule is an acetylated, amidated peptide, meaning both ends of the chain are chemically capped, a common modification intended to slow enzymatic breakdown.

Mechanistic family

The rationale for this whole ingredient class was described when the parent hexapeptide was introduced: researchers reported that the hexapeptide was patterned after the N-terminal end of SNAP-25 and that it interfered with the formation of the SNARE complex involved in vesicle docking, which in their in vitro work reduced catecholamine release from chromaffin cells (PMID 18498523). SNAP-8 is described in the cosmetic literature as an extended analogue of that same N-terminal motif. Importantly, mimicking a mechanism is not the same as demonstrating it in human skin, and the verified papers summarised here did not test acetyl octapeptide-3 directly.

Regulatory position

Peptides of this type are handled as cosmetic ingredients, not as approved drugs. They are not injected botulinum products and are not regulated as such. Within the cosmetic-ingredient safety system, the closely related acetyl hexapeptide-8 amide has been through a formal safety review: the expert panel that conducted it reported a conclusion of safety in the present practices of use and concentration described in that assessment (PMID 40673537). Research-grade peptide material sold for laboratory work is a separate category again and is labelled for research use only.

How the term is used in peptide research

In the published literature, the phrase most often appearing is acetyl hexapeptide-8 (Argireline), with SNAP-8 mentioned as a related cosmetic ingredient. Reviews of cosmeceuticals for photoageing grouped these molecules among “neurotransmitter-inhibiting” or “neuropeptide” cosmetic actives alongside signal peptides, carrier peptides and enzyme-inhibiting peptides (PMID 39233460). Dermatology writing has also used the hexapeptide as an example when discussing temporary cosmetic camouflage of scars and wrinkles (PMID 33151254). Interest in the ingredient class is measurable outside the laboratory too: an analysis of public search behaviour tracked attention to acetyl hexapeptide-8 over time and reported that consumer interest rose across the study window (PMID 38376906).

Where the term is misused

• Treated as a systemic or injectable peptide. SNAP-8 appears in topical cosmetic chemistry. The verified literature contains no injection studies of it, and none of the papers cited here examined systemic administration.
• Called “topical Botox”. Botulinum toxin is a large bacterial protein delivered by injection; SNAP-8 is a small peptide applied to the skin surface. The comparison is a marketing shorthand, not an equivalence shown in the cited studies.
• Confused with Argireline. Argireline is acetyl hexapeptide-8 (six residues). SNAP-8 is acetyl octapeptide-3 (eight residues). Data generated for one are frequently reprinted as though they belonged to the other.
• Confused with other “SNAP” abbreviations. In pharmacology, SNAP also denotes S-nitroso-N-acetylpenicillamine, a nitric oxide donor, and SNAP-25 is the human protein itself. These are unrelated to the cosmetic ingredient.
• Assumed to reach deep skin layers automatically. Permeability is the central technical question for this class, and it was the explicit subject of several of the studies below.

What the published literature reports

Skin permeation

A dedicated review of acetyl hexapeptide-8 in cosmeceuticals examined skin permeability and efficacy together, noting that the stratum corneum is the limiting barrier for a hydrophilic, charged peptide of this size (PMID 40565185). An in vitro penetration study using a cosmetic formulation measured how much peptide was recovered in different skin compartments and reported that penetration was limited and formulation-dependent (PMID 24754410). A separate study compared emulsions and reported that emulsion composition and internal structure influenced topical delivery of the peptide (PMID 25497319).

Two further lines of work addressed the same barrier. Researchers who chemically modified anti-wrinkle peptides reported enhanced skin permeation of the modified molecules relative to the unmodified peptides in their experimental models (PMID 29371611), and a monocentric clinical study delivered bioactive peptides on hyaluronic acid microneedle patches, an approach designed to bypass the stratum corneum mechanically (PMID 31134751).

Reported cosmetic and laboratory effects

The foundational hexapeptide paper described both mechanism and a small human observation: the study applied a 10% w/v preparation of the hexapeptide in an oil/water emulsion and researchers reported a reduction in wrinkle depth of up to 30% after 30 days in a small group of healthy female volunteers (PMID 18498523). That report concerned the hexapeptide, was small, and predates the more detailed permeability work summarised above (PMID 40565185). In cell culture, an evaluation of five cosmeceutical peptide mixtures reported protective effects against hydrogen peroxide-induced premature senescence in human skin fibroblasts (PMID 33849044).

Safety and tolerability: What Studies Report

The most relevant safety document in the verified set is the cosmetic safety assessment of acetyl hexapeptide-8 amide, in which the reviewing panel evaluated the available toxicology and reported a conclusion of safety in the present practices of use and concentration described (PMID 40673537). Reviews of cosmeceuticals in photoageing have likewise discussed peptide actives as generally well tolerated topical ingredients while noting variability in evidence quality across the category (PMID 39233460). No adverse-event data specific to acetyl octapeptide-3 appear in the papers cited on this page, and the microneedle-patch clinical work involved a different delivery route from a leave-on cosmetic (PMID 31134751).

Related terms

• Acetyl hexapeptide-8 / acetyl hexapeptide-3 / Argireline — the six-residue relative that carries most published data (PMID 40565185).
• SNAP-25 — the human SNARE protein whose N-terminal region the peptide family imitates (PMID 18498523).
• SNARE complex — the protein assembly that mediates vesicle docking and fusion.
• Cosmeceutical — an informal category for cosmetic products marketed with bioactive claims (PMID 39233460).
• Stratum corneum — the outermost skin layer that governs topical peptide permeation (PMID 24754410).

How to read claims about SNAP-8

1. Check whether a claim names acetyl octapeptide-3 or acetyl hexapeptide-8; the two are routinely swapped.
2. Check whether the evidence is in vitro, in a formulation model, or in people — the cited permeation studies were laboratory models (PMID 24754410).
3. Check the vehicle, because researchers reported that emulsion structure changed delivery outcomes (PMID 25497319).
4. Check sample size and duration; the early human observation involved a small volunteer group over 30 days (PMID 18498523).

References

• A synthetic hexapeptide (Argireline) with antiwrinkle activity (International Journal of Cosmetic Science, 2002)
• Acetyl Hexapeptide-8 in Cosmeceuticals—A Review of Skin Permeability and Efficacy (International Journal of Molecular Sciences, 2025)
• In vitro skin penetration of acetyl hexapeptide-8 from a cosmetic formulation (Cutaneous and Ocular Toxicology, 2015)
• Topical delivery of acetyl hexapeptide-8 from different emulsions: influence of emulsion composition and internal structure (European Journal of Pharmaceutical Sciences, 2015)
• Enhanced Skin Permeation of Anti-wrinkle Peptides via Molecular Modification (Scientific Reports, 2018)
• Efficacy of bioactive peptides loaded on hyaluronic acid microneedle patches: A monocentric clinical study (Journal of Cosmetic Dermatology, 2020)
• Protective and Anti-Aging Effects of 5 Cosmeceutical Peptide Mixtures on Hydrogen Peroxide-Induced Premature Senescence in Human Skin Fibroblasts (Skin Pharmacology and Physiology, 2021)
• Safety Assessment of Acetyl Hexapeptide-8 Amide as Used in Cosmetics (International Journal of Toxicology, 2025)
• Cosmeceuticals in photoaging: A review (Skin Research and Technology, 2024)
• Skin scars and wrinkles temporary camouflage in dermatology and oncoesthetics: focus on acetyl hexapeptide-8 (La Clinica Terapeutica, 2020)
• Public Interest in Acetyl Hexapeptide-8: Longitudinal Analysis (JMIR Dermatology, 2024)